|
INCREASES RISK OF HEPATOTOXICITY
|
DRUGS CAUSING MYELOSUPPRESSION CAN EXACERBATE THE EFFECTS OF INTERFERON
|
DRUGS CAUSING MYELOSUPPRESSION CAN EXACERBATE THE EFFECTS OF INTERFERON
|
ZIDOVUDINE HEMATOTOXICITY IS INCREASED
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
CO-ADMINISTRATION OF INTERFERON ALFA-2A WITH THEOPHYLLINE HAS BEEN REPORTED TO REDUCE THE THEOPHYLLINE CLEARANCE
|
CO-ADMINISTRATION OF INTERFERON ALFA-2A WITH THEOPHYLLINE HAS BEEN REPORTED TO REDUCE THE THEOPHYLLINE CLEARANCE
|
PARACETAMOL HAS BEEN FOUND TO ENHANCE THE ANTIVIRAL EFFECTS OF INTERFERON
|
THEOPHYLLIN PLASMA CONCENTRATION IS RAISED BY THE DRUG
|
THEOPHYLLIN PLASMA CONCENTRATION IS RAISED BY THE DRUG
|
THEOPHYLLIN PLASMA CONCENTRATION IS RAISED BY THE DRUG
|
CO-ADMINISTRATION CAN DEVELOP OR EXACERBATE GLOMERULONEPHRITIS, OCULO-BULBER MYASTHENIA GRAVIS, ARTHRITIS, THYRODITIS, BULLOUS PAMPHIGOID & STEVENS-JOHNSON SYNDROME, CROHNS DISEASE, SCLERODERMA, DIABETES, CEREBRAL VASCULITIS ETC.
|